Amanote Research
Register
Sign In
Bilateral Uveitis After Intravesical BCG Immunotherapy for Bladder Carcinoma
British Journal of Ophthalmology
- United Kingdom
doi 10.1136/bjo.86.6.706
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Date
June 1, 2002
Authors
M Wertheim
Publisher
BMJ
Related search
The Use of Intravesical BCG in Urothelial Carcinoma of the Bladder
ecancermedicalscience
Cancer Research
Oncology
Septic Shock After Intravesical BCG Instillation—A Case Report
Advances in Infectious Diseases
Intravesical Administration of Misonidazole in Bladder Carcinoma
Acta Radiologica: Oncology
Intravesical Immunotherapy of Superficial Bladder Cancer With Chitosan/Interleukin-12
Cancer Research
Cancer Research
Oncology
A Possible Mechanism of Intravesical BCG Therapy for Human Bladder Carcinoma: Involvement of Innate Effector Cells for the Inhibition of Tumor Growth
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
IL-9 BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer in Europe
Japanese Journal of Urology
Urology
Intravesical Therapy – BCG and Beyond
Bladder Cancer
Oncology
Urology
Old Instillations and New Implications in Bladder Cancer: The Urinary Microbiome and Intravesical BCG
BJU International
Urology
Mycobacterium Bovis BCG Vertebral Osteomyelitis After Intravesical BCG Therapy, Diagnosed by PCR-Based Genomic Deletion Analysis
Journal of Clinical Microbiology
Microbiology